Silence Therapeutics Plc (SLNCF)
3.85
0.00 (0.00%)
USD |
OTCM |
Oct 13, 16:00
Silence Therapeutics EPS Diluted (TTM) : -0.4231 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4231 |
| March 31, 2026 | -0.5295 |
| December 31, 2025 | -0.6254 |
| September 30, 2025 | -0.791 |
| June 30, 2025 | -0.7831 |
| March 31, 2025 | -0.6076 |
| September 30, 2024 | -0.5566 |
| June 30, 2024 | -0.4012 |
| March 31, 2024 | -0.3812 |
| Date | Value |
|---|---|
| December 31, 2023 | -0.4786 |
| September 30, 2023 | -0.4779 |
| June 30, 2023 | -0.4692 |
| March 31, 2023 | -0.516 |
| December 31, 2022 | -0.5159 |
| September 30, 2022 | -0.3662 |
| June 30, 2022 | -0.2816 |
| March 31, 2022 | -0.1148 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -6.696 |
| NuCana Plc | -3.220 |
| Mereo BioPharma Group Plc | -0.1752 |
| Compass Pathways Plc | -4.624 |
| HemoGenyx Pharmaceuticals Plc | -2.422 |